ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,051Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 378

$959K Total Retail Price of All Prescriptions

Rank: 4 out of 378

616 Patients Receiving at Least One Drug in Part D
25% Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Virginia
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

5% of this provider’s 616 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

3% of this provider’s 616 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Brand Name Drugs*

13% of this provider’s prescriptions were for brand-name drugs, compared to an average of 16%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $97 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Virginia
LORAZEPAM 784 96 141 B 1 6
QUETIAPINE FUMARATE 764 119 103 A 2 1
BENZTROPINE MESYLATE 762 113 105 R 3 5
RISPERIDONE 728 151 94 A 4 3
ALPRAZOLAM 528 84 85 B 5 9
OLANZAPINE 522 183 76 A 6 8
DIVALPROEX SODIUM 509 52 69 7 21
TRAZODONE HCL 496 114 88 8 4
CITALOPRAM HBR 448 128 77 9 10
CLONAZEPAM 371 45 62 B 10 2
HALOPERIDOL 330 43 56 A 11 23
MIRTAZAPINE 314 99 56 12 19
LITHIUM CARBONATE 310 64 39 13 13
DIVALPROEX SODIUM ER 308 33 61 14 18
CLOZAPINE 245 16 18 A 15 16
ESCITALOPRAM OXALATE 245 89 32 15 17
FLUOXETINE HCL 232 55 36 17 12
ZIPRASIDONE HCL 230 48 31 A 18 29
TOPIRAMATE 204 20 32 19 30
HALOPERIDOL DECANOATE 191 <11 35 A 20 37
LAMOTRIGINE 173 <11 28 21 14
VENLAFAXINE HCL ER 168 47 33 22 20
ZOLPIDEM TARTRATE 162 29 43 23 22
ABILIFY 156 18 29 A 24 11
TEMAZEPAM 156 41 31 B 24 39
SERTRALINE HCL 154 34 41 26 7
PAROXETINE HCL 151 29 19 27 28
CHLORPROMAZINE HCL 127 21 16 A 28 40
DIAZEPAM 119 13 16 B 29 31
HYDROXYZINE PAMOATE 114 <11 23 R 30 32
SUBOXONE 105 0 12 S3 31 42
OXCARBAZEPINE 104 <11 17 32 38
BUSPIRONE HCL 93 11 15 33 27
LOXAPINE 90 29 11 A 34 59
CYMBALTA 90 32 24 34 15
FLUPHENAZINE HCL 83 22 11 A 36 45
DONEPEZIL HCL 82 69 19 37 35
GABAPENTIN 79 <11 23 38 26
LEVETIRACETAM 72 <11 14 39 90
RISPERDAL CONSTA 70 <11 <11 A 40 34
CARBAMAZEPINE 70 <11 13 40 44
INVEGA 67 <11 <11 A 42 53
AMPHETAMINE SALT COMBO 62 <11 12 S2 43 33
BUPROPION HCL SR 58 16 13 44 25
PROPRANOLOL HCL 57 <11 <11 45 48
PANTOPRAZOLE SODIUM 56 <11 19 46 92
NAMENDA 52 <11 <11 47 43
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.